GRHL3 and ulcerative colitis: Recent evidence demonstrates significant changes in SOM expression in idiopathic inflammatory bowel diseases [16], Crohn's disease, ulcerative colitis [17], chemically induces colitis [29], proliferative enteropathy, and chemically driven inflammation of porcine descending colon [15].